Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

GlobalData: COVID-19 has pushed infectious disease drugs to top therapy area for CSAs

Infectious disease drugs have overtaken oncology as the year’s top therapy area for contract service agreements as companies are shifting their current focus to developing treatments to battle the COVID-19 pandemic.

25 Jul 2020

Stäubli introduces CombiTac direqt

For years, Stäubli Electrical Connectors has been successfully providing a range of connector solutions that combine high-quality power, signal, data, pneumatic and fluid connections in a single modular connector system known as CombiTac.The CombiTac system offers customers worldwide a compact and space-saving modular connector solution that can be adapted and customized to meet exact dimensional and technical requirements, and guarantees a safe and steady performanceeven under the most demanding mechanical and environmental conditions.

From Stäubli Electrical Connectors 24 Jul 2020

Eikonoklastes Therapeutics announces closing of oversubscribed seed financing

Eikonoklastes Therapeutics, a preclinical stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases with unmet clinical need, today announced closing of an oversubscribed seed financing.

23 Jul 2020

Researchers detect fluoroethers in blood of Wilmington residents

In a new paper detailing findings from North Carolina State University's GenX Exposure Study, researchers detected novel per- and polyfluoroalkyl substances (PFAS) called "fluoroethers" in blood from residents of Wilmington, North Carolina.

23 Jul 2020

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in specific tissues of interest.

23 Jul 2020

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.

22 Jul 2020

Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies

Thermo Fisher Scientific Inc., the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting more than 200 of these projects globally.

From Thermo Fisher Scientific Inc. 22 Jul 2020

Sartorius raises 2020 sales and earnings forecast based on dynamic performance in the first half

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, raised its growth and earnings guidance for the current year based on its very dynamic business performance in the first six months of 2020, as well as on high demand expected to continue for the rest of the current fiscal year.

From Sartorius 22 Jul 2020

Monash University researchers pave way for affordable immunotherapies

Researchers from Monash University’s Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world’s newest forms of immunotherapy: CAR-T cell therapy.

22 Jul 2020

Case Western Reserve University scientist receives DoD grant to develop freeze-dried artificial platelets

A Case Western Reserve University scientist, who has for more than a decade pioneered research into synthetic platelet substitutes, has been awarded a $3.8 million grant by the U.S. Department of Defense (DOD) to develop freeze-dried artificial platelets that can treat bleeding in wounded soldiers in the battlefield before they can be taken to a hospital.

22 Jul 2020

Stanford researchers develop a portable device for rapidly detecting blood ammonia levels

Seated around the dinner table, faculty affiliated with Stanford ChEM-H - one of Stanford University's interdisciplinary institutes - spoke one-by-one, pitching ideas for collaborative research.

21 Jul 2020

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

A new study published on the preprint server medRxiv by a research group from the U.S. and Germany indicates that a novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) induces functional and proinflammatory T cell responses in almost all participants – marking another landmark achievement for this promising vaccine candidate.

21 Jul 2020

Wyss Institute's tough gel adhesive technology licensed to Amend Surgical

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that its tough gel adhesive technology has been licensed by Amend Surgical, a Florida-based medical device company focused on developing and manufacturing novel biomaterials.

21 Jul 2020

China’s progress in developing COVID-19 vaccines could surprise the world, GlobalData says

China is among the leading countries that are aggressively involved in developing vaccines for COVID-19, with one vaccine each from Sinopharm Group and Sinovac Biotech entering Phase 3 clinical development.

21 Jul 2020

COVID-19 vaccine displays protective traits in nonhuman primates

A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion that goes by the acronym LION, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. These antibodies potently neutralize the virus.

20 Jul 2020

New assay improves detection of SARS-CoV-2 antibodies

Researchers at the University of California Santa Cruz have developed a new assay for the detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that they say provides significant advantages over the techniques currently used.

20 Jul 2020

Olympus scanR high-content screening station v. 3.2 brings improved image quality with award-winning X Line objectives

The scanR high-content screening (HCS) station version 3.2 delivers improved image quality, better quantitative data, support for challenging segmentation and classification applications and increased speed to help life science researchers maximize the information they get from their samples.

From Evident Corporation - Life Sciences 20 Jul 2020

Researchers are producing COVID-19 spike proteins to prevent future infections

On July 1, the Texas A&M Engineering Experiment Station's National Center for Therapeutics Manufacturing received funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals to help find a way to prevent the SARS-CoV-2 virus from binding to cells, protecting people from future infections.

19 Jul 2020

A coronavirus vaccine: Where does it stand?

More than four months into the coronavirus pandemic, how close are the U.S. and the world to a safe and effective vaccine? Scientists say they see steady progress and are expressing cautious optimism that a vaccine could be ready by spring.

16 Jul 2020

Study finds significant variability in the accuracy of currently available COVID-19 antibody tests

A new peer-reviewed study by researchers at NSF International and Novateur Ventures finds significant variability in the accuracy of currently available COVID-19 antibody tests.

15 Jul 2020

Manufacturing News and Research

Further Reading

GlobalData: COVID-19 has pushed infectious disease drugs to top therapy area for CSAs

Stäubli introduces CombiTac direqt

Eikonoklastes Therapeutics announces closing of oversubscribed seed financing

Researchers detect fluoroethers in blood of Wilmington residents

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies

Sartorius raises 2020 sales and earnings forecast based on dynamic performance in the first half

Monash University researchers pave way for affordable immunotherapies

Case Western Reserve University scientist receives DoD grant to develop freeze-dried artificial platelets

Stanford researchers develop a portable device for rapidly detecting blood ammonia levels

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

Wyss Institute's tough gel adhesive technology licensed to Amend Surgical

China’s progress in developing COVID-19 vaccines could surprise the world, GlobalData says

COVID-19 vaccine displays protective traits in nonhuman primates

New assay improves detection of SARS-CoV-2 antibodies

Olympus scanR high-content screening station v. 3.2 brings improved image quality with award-winning X Line objectives

Researchers are producing COVID-19 spike proteins to prevent future infections

A coronavirus vaccine: Where does it stand?

Study finds significant variability in the accuracy of currently available COVID-19 antibody tests

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest Life Science News